RPG Investment Advisory’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-63,325
Closed -$6.53M 92
2021
Q4
$6.53M Sell
63,325
-1,171
-2% -$108K 1.01% 54
2021
Q3
$5.47M Sell
64,496
-961
-1% -$80.5K 0.9% 63
2021
Q2
$5.46M Sell
65,457
-12,397
-16% -$1.02M 0.89% 63
2021
Q1
$5.86M Sell
77,854
-1,799
-2% -$131K 1.05% 52
2020
Q4
$5.44M Buy
79,653
+717
+0.9% +$46.6K 1.09% 48
2020
Q3
$4.61M Buy
78,936
+758
+1% +$47.2K 1.13% 47
2020
Q2
$5.08M Sell
78,178
-26,361
-25% -$1.66M 1.34% 36
2020
Q1
$6.2M Buy
104,539
+27,241
+35% +$1.82M 1.76% 16
2019
Q4
$5.74M Sell
77,298
-17,962
-19% -$1.26M 1.32% 36
2019
Q3
$6.01M Buy
95,260
+2,773
+3% +$164K 1.43% 30
2019
Q2
$5.05M Buy
92,487
+91,962
+17,517% +$4.95M 1.19% 42
2019
Q1
$28K Hold
525
0.01% 137
2018
Q4
$34K Sell
525
-110
-17% -$8.21K 0.01% 123
2018
Q3
$50K Hold
635
0.01% 117
2018
Q2
$41K Hold
635
0.01% 131
2018
Q1
$40K Buy
635
+336
+112% +$24.1K 0.01% 168
2017
Q4
$22K Hold
299
0.01% 211
2017
Q3
$24K Buy
299
+239
+398% +$18.9K 0.01% 190
2017
Q2
$5K Buy
+60
New +$4.74K ﹤0.01% 242

Other funds holding CVS

RPG Investment Advisory's CVS Position: Q1 2022 in Review

RPG Investment Advisory sold out of CVS Health (CVS) in Q1 2022, closing a stake of 63,325 shares — an estimated $6.53M sold.

RPG Investment Advisory first reported a position in CVS in Q2 2017 and held it in 19 quarters. The position peaked at $6.53M in Q4 2021. 2,365 funds tracked by Wall St. Rank hold CVS as of Q1 2022.

  • RPG Investment Advisory reported no remaining CVS Health position as of Q1 2022 after selling out during the quarter.
  • RPG Investment Advisory sold 63,325 CVS Health shares in Q1 2022, an estimated $6.53M.
  • RPG Investment Advisory first reported a position in CVS Health in Q2 2017 and held it in 19 quarters.
  • RPG Investment Advisory's CVS Health position peaked at $6.53M in Q4 2021.
  • 2,365 funds tracked by Wall St. Rank held CVS Health as of Q1 2022.

Based on RPG Investment Advisory's 13F filing for Q1 2022, filed 10 May 2022.